Combined analysis of GAD65 and ICA512(IA-2) autoantibodies in organ and non-organ-specific autoimmune diseases confers high specificity for insulin-dependent diabetes mellitus

Journal of Autoimmunity

Volumn 11, Issue 1, 1998, Pages 1-10

  Pietropaolo, Massimo ^a   Peakman, Mark ^a   Pietropaolo, Susan L ^a   Zanone, Maria M ^b   Foley Jr , Thomas P ^a   Becker, Dorothy J ^a   Trucco, Massimo ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b NONE

Author keywords

Autoimmune thyroid diseases; GAD65; ICA512(IA 2); IDDM; Primary biliary cirrhosis

Indexed keywords

AUTOANTIBODY; GLUTAMATE DECARBOXYLASE; PANCREAS ISLET CELL ANTIBODY;

ANTIBODY SPECIFICITY; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; THYROID DISEASE;

EID: 0031939509     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1997.0170     Document Type: Article

References (60)

1. Bingley P.J., Christie M.R., Bonifacio E., Bonfanti R., Shattock M., Fonte M.T., Bottazzo G.F., Gale E.A.M., 1994. Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes 43: 1304-1310
2. Verge C.F., Gianani R., Kawasaki E., Yu L., Pietropaolo M., Jackson R.A., Chase P.H., Eisenbarth G.S. 1996. Prediction of type I diabetes mellitus in first degree relatives using a combination of insulin, glutamic acid decarboxylase and ICA512bdc/IA-2 autoantibodies. Diabetes 45: 926-933
3. Kawasaki E., Eisenbarth G.S., Wasmeier C., Hutton J.C. 1996. Autoantibodies to protein tyrosine phosphatase-like proteins in type 1 diabetes: overlapping specificities to phogrin and ICA512(IA-2). Diabetes 45: 1344-1349
4. Lan M.S., Wasserfall C., Maclaren N.K., Notkins N.L. 1996. IA-2, a transmembrane protein of the protein tyrosine phosphatase family, is a major autoantigen in insulin-dependent diabetes mellitus. Proc. Natl. Acad. Sci. USA 93: 6367-6370
5. Wiest-Ladenburger U., Hartmann R., Hartmann U., Berling K., Bohm B.O., Richter W. 1997. Combined analysis and single-step detection of GAD65 and IA2 autoantibodies can replace the histochemical islet cell antibody test. Diabetes 46: 565-571
6. Gorus F.K., Goubert P., Semakula C., Vanderwalle C.L., de Schepper J., Scheen A., Christie M.R., Pipeleers D.G., the Belgian Diabetes Registry 1997. IA-2 autoantibodies complement GAD65 autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings. Diabetologia 40: 95-99
7. Pietropaolo M., Eisenbarth G.S. 1994. Molecular targets of the autoimmunity of type L diabetes. In Molecular Biology of Diabetes. B. Draznine, D. LeRoith, eds. Humana Press Inc., Totowa, New Jersey pp. 1-33.
8. Atkinson M.A., Maclaren N.K. 1993. Islet cell autoantigens in insulin-dependent diabetes. J. Clin. Invest. 92: 1608-1616
9. Palmer J.P., Asplin C.M., Clemons P., Lyen K., Tatpati O., Raghu O., Paquette T.L. 1983. Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 222: 1337-1339
10. Solimena M., Folli F., Denis-Donini S., Comi G.C., Pozza G., De Camilli P., Vicari A.M. 1988. Autoantibodies to glutamic acid decarboxylase in a patient with stiffman syndrome, epilepsy, and Type I diabetes mellitus. N. Engl. J. Med. 318: 1012-1020
11. Baekkeskov S., Aanstoot H., Christgau S., Reetz A., Solimena M.S., Cascalho M., Folli F., Richter-Olsen H., DeCamilli P. 1990. Identification of the 64K autoantigen in insulin dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347: 151-156
12. Rabin D.U., Pleasic S.M., Shapiro J.A., Yoo-Warren H., Oies J., Hicks J.M., Goldstein D.E., Rae P.M.M. 1994. Islet cell antigen 512 is a diabetes-specific islet autoantigen related to protein tyrosine phosphatases. J. Immunol. 152: 3183-3188
13. Lan M.S., Lu J., Notkins A.L. 1994. Molecular cloning and identification of a receptor-type protein tyrosine phosphatase, IA-2, from human insulinoma. DNA Cell. Biol. 13: 505-514
14. Wasmeier C., Hutton J.C. 1996. Molecular cloning of phogrin, a protein tyrosyne phosphatase homologue localized to insulin secretory granule membranes. J. Biol. Chem. 271: 18161-18170
15. Solimena M., Dirkx R. Jr, Hermel J.-M., Pleasic-Williams S., Shapiro J.A., Caron L., Rabin D.U. 1996. ICA512, an autoantigen of type I diabetes, is an intrinsic membrane protein of neurosecretory granules. EMBO J. 15: 2102-2114
16. Pietropaolo M., Hutton J.C., Eisenbarth G.S. 1997. Protein-tyrosine phosphatase-like proteins: link with insulin-dependent diabetes mellitus. Diabetes Care 20: 208-214
17. Payton M.A., Hawkes C.J., Christie M.R. 1995. Relationship of the 37,000- and 40,000-Mr tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosyne phosphatase-like molecule IA-2 (ICA512). J. Clin. Invest. 96: 1506-1511
18. Bonifacio E., Lampasona V., Genovese S., Ferrari M., Bosi E. 1995. Identification of protein tyrosine phosphatase-like UA2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37/40K autoantigen and a target of islet-cell antibodies. J. Immunol. 155: 5419-5426
19. Passini J.D., Larigan J.D., Genovese S., Appella E., Sinigaglia F., Rogge L. 1995. The 37/40-kilodalton autoantigen in insulin-dependent diabetes mellitus is the putative tyrosine phosphatase IA-2. Proc. Natl. Acad. Sci. USA 92: 9412-9416
20. Notkins A.L., Zhang B., Matsumoto Y., Lan M.S. 1997. Comparison of IA-2 with IA-2 beta and with six other members of the protein tyrosine phosphatase family: recognition of antigenic determinants by IDDM sera. J. Autoimmun. 10: 245-250
21. Pietropaolo M., Eisenbarth G.S. 1994. Combined biochemical analysis may enhance specificity. Diabetes Prevention Therapy 8(4): 37-38
22. Wagner R., McNally J.M., Bonifacio E., Genovese S., Foulis A., McGill M., Christie M.R., Betterle C., Bosi E., Bottazzo G.F. 1994. Lack of immunohistological changes in the islets of nondiabetic, autoimmune, polyendocrine patients with b-selective GAD-specific islet cell antibodies. Diabetes 43: 851-856
23. Kawasaki E., Takino H., Yano M., Uotani S., Matsumoto K., Takao Y., Yamaguchi Y., Akazawa S., Nagataki S. 1994. Autoantibodies to glutamic acid decarboxylase in patients with IDDM and autoimmune thyroid disease. Diabetes 43: 80-86
24. Kawasaki E., Abiru N., Yano M., Uotani S., Matsumoto K., Matsuo H., Yamasaki H., Yamamoto H, Yamaguchi Y., Azakawa S., Nagataki S. 1995. Autoantibodies to glutamic acid decarboxylase in patients with autoimmune thyroid disease: relation to competitive insulin autoantibodies. J. Autoimmun. 8: 633-643
25. Hallengren B., Falorni A., Landin-Olsson M., Lernmark A., Papadopoulos K.I., Sundkvist G. 1996. Islet cell and glutamic acid decarboxylase antibodies in hyperthyroid patients: at diagnosis and following treatment. J. Intern. Med. 239: 63-68
26. Christie M.R., Genovese S., Cassidy D., Bosi E., Brown T.J., Lai M., Bonifacio E., Bottazzo G.F. 1994. Antibodies to islet 37 k antigen, but not to glutamate decarboxylase, discriminate rapid progression to IDDM in endocrine autoimmunity Diabetes 43: 1254-1259
27. Ericsson U.-B., Christensen S.B., Thorell J.I. 1985. A high prevalence of thyroglobulin autoantibodies in adults with and without thyroid diseases as measured with a sensitive solid-phase immunosorbent radioassay. Clin. Immunol. Immunopath. 37: 154-162
28. Beever K., Bradbury J., Phillips D., McLachlan S.M., Pegg S.M., Goral C., Overbeck. In W., Feifel G., Rees Smith B. 1989. Highly sensitive assays of autoantibodies to thyroglobulin and thyroid peroxidase. Clin. Chem. 35: 1949-1554
29. Kung V.T., Weber P.M., dos Remedios R.V. 1981. Double-antibody radioimmunoassay of thyroid microsomal antibody in serum. Clin. Chem. 27: 39
30. Wagener D.K., Sacks J.M., LaPorte R.E., MacGregor G.M. 1982. The Pittsburgh study of insulin-dependent diabetes mellitus: risk for diabetes among relatives of IDDM. Diabetes 31: 136-144
31. LaPorte R.E., Fishbein H.A., Drash A.L., Kuller L.H., Schneider B.B., Orchard R.J., Wagener D.K. 1981. The Pittsburgh insulin-dependent diabetes mellitus (IDDM) registry. The incidence of insulin-dependent diabetes mellitus in Allegheny country, Pennsylvania (1965-1976). Diabetes 30: 279-291
32. Lipton R.B., Kocova M., LaPorte R.E., Dorman J.S., Orchard T.J., Riley W.J., Drash A.L., Becker D.J., Trucco M. 1992. Autoimmunity and genetic factors contribute to the risk of insulin-dependent diabetes mellitus in families: islet cell antibodies and HLA DQ heterodimers. Am. J. Epidemiol. 136: 503-512
33. National Diabetes Data Group 1979. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28: 1039-1057
34. Grubin C.E., Daniels T., Toivola B., Landin-Olsson M., Hagopian W.A., Li L., Karlsen A.E., Boel E., Michelson B., Lernmark A. 1994. A novel radiobinding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia 37: 344-350
35. Gianani R., Rabin D.U., Verge C.F., Yu L., Babu S.R., Pietropaolo M., Eisenbarth G.S. 1995. ICA512 autoantibody radioassay. Diabetes 44: 1340-1344
36. Winer B.J., Brown D.R., Michels K.M. 1991. In Statistical Principles in Experimental Design. McGraw-Hill, New York
37. nd (3), National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. NIH Publication No. 95-1468, pp. 37-46
38. McNeil B.J., Hanley J.A. 1984. Statistical approaches to the analysis of receiver operating characteristic (ROC) curves. Med. Decis. Making 4: 137-150
39. Svensson E., Holm S. 1994. Separation of systematic and random differences in ordinal rating scales. Stat. Med. 13: 2437-2453
40. Coopan R., Kozak G.P. 1980. Hyperthyroidism and diabetes mellitus. Arch. Intern. Med. 140: 370-373
41. Gray R.S., Herd R., Clarke B.F. 1981. The clinical features of diabetes with coexisting autoimmune thyroid disease. Diabetologia 20: 602-606
42. Nerup J., Binder C. 1973. Thyroid, gastric and adrenal auto-immunity in diabetes mellitus. Acta Endocrinol. 72: 279-286
43. Bottazzo G.E, Pujol-Borrell R., Gale E.A.M. 1987. Autoimmunity and type I diabetes: bringing the story up to date. In The Diabetes Annual. K.G.M.M. Alberti, L.P. Krall eds. Elsevier Science Publishers, pp. 15-38
44. Riley W.J. Maclaren N.K., Lezotte D.C., Spillar R.P., Rosenbloom A.L. 1981. Thyroid autoimmunity in insulin-dependent diabetes mellitus: the case for routine screening. J. Pediatr. 99: 350-354
45. Riley W.J., Winer A., Goldstein D. 1983. Coincident presence of thyro-gastric autoimmunity at onset of type 1 (insulin-dependent) diabetes. Diabetologia 24: 418-421
46. Roman S., Davies T., Witt M., Ginsberg-Fellner F., Rubinstein P. 1996. Thyroid autoantibodies in HLA-genotyped type I diabetic families: sex-limited DR5 association with thyroid microsomal antibodies. Clin. Endocrinol. 25: 23-33
47. Picco P., Mazzell M., Cotellessa M., Pistoia V. 1991. Autoimmune thyroiditis in IDDM patients. Diabetes Care 14: 1107-1109
48. Landin-Olsson M., Karlsson F.A., Lernmark A., Sundkvist G. and the Diabetes Incidence Study in Sweden Group 1992. Islet cell and thyrogastric antibodies in 633 consecutive 15- and 34-yr-old patients in the diabetes incidence study in Sweden. Diabetes 41: 1022-1027
49. Abrams P., De Leeuw I., Vertommen J., the Belgian Diabetes Registry 1996. In new onset insulin dependent diabetic patients the presence of anti-thyroid peroxidase antibodies is associated with islet cell autoimmunity and the high risk haplotype HLA DQA1 *0301-DQB1 0302. Diabetic Med. 13: 415-419
50. Andersson D.K.G., Svardsudd K., Tibblin G. 1991. Prevalence and incidence of diabetes in a Swedish community 1972-1987. Diabetic Med. 8: 428-434
51. Donner H., Rau H., Walfish P.G., Braun J., Siegmund T., Finke R., Herwing J., Usadel K.H., Badenhoop K. 1997. CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to Type 1 diabetes mellitus. J. Clin. Endocrinol. Metab. 82: 143-146
52. Eisenbarth G.S. 1986. Type I diabetes mellitus: a chronic autoimmune disease. N. Engl. J. Med. 314: 1360-1368
53. Christie M.R., Roll U., Payton M.A., Hatfield E.C.I., Ziegler A.G. 1997. Validity of screening for individuals at risk for type I diabetes by combined analysis of antibodies to recombinant proteins. Diabetes Care 20: 965-970
54. Martino G.V., Grimaldi L.M.E., Bazzigaluppi E., Passini N., Sinigaglia F., Rogge L. 1996. The insulin-dependent diabetes mellitus-associated ICA 105 autoantigen in stiff man syndrome patients. J. Neuroimmunol. 69: 129-134
55. Sanjeevi C.B., Falorni A., Robertson J., Lernmark A. 1996. Glutamic acid decarboxylase (GAD) in insulin-dependent diabetes mellitus. Diabetes Nutr. Metab. 9: 167-182
56. Baum H., Butler P., Sternberg M., Burroughs A. 1993. Autoimmune disease and molecular mimicry: an hypothesis. Trends Biochem. Sci. 18: 140-144
57. Leung P.S.C., Van de Winter J., Coppel R.L., Nakanuma Y., Munoz S., Gershwin M.E. 1996. Molecular aspects and pathological basis of primary biliary cirrhosis. J. Autoimmun. 9: 119-128
58. Baum H., Davies H., Peakman M. 1996. Molecular mimicry in the MHC: hidden clues to autoimmunity? Immunol. Today 17: 64-70
59. Butler P., Hamilton-Miller J., Baum H., Burroughs A.K. 1995. Detection of M2 antibodies in patients with recurrent urinary tract infection using an ELISA and purified specific antigens. Evidence for a molecular mimicry mechanism in the pathogenesis of primary biliary cirrhosis? Biochem. Mol. Biol. 35: 473-485
60. Vandewalle C.L., Falorni A., Svanholm S., Lernmark A., Pipeleers D.G., Gorus F.K. The Belgian Diabetes Registry 1995. High diagnostic sensitivity of glutamate decarboxylase autoantibodies in insulin-dependent diabetes mellitus with clinical onset between age 20 and 40 years. J. Clin. Endocrinol. Metab. 80: 846-851